Corporate Advisory Council
The American Brain Coalition (ABC) is a unique nonprofit membership organization drawn from patients, researchers, clinicians, universities, government agencies, and corporations. Together, we raise awareness for increased support of research that leads to better treatment; services and support that improves patients’ quality of life; as well as a national commitment towards finding cures for individuals with disabling neurological and psychiatric disorders.
Corporate members within the ABC are comprised of leading companies that recognize the importance of partnering with those committed to helping people with brain diseases and disorders. Corporate members include pharmaceutical, biotech, and medical device companies that are developing or marketing therapeutic or diagnostic products.
ABC corporate members may designate one individual to represent them on the ABC’s Corporate Advisory Council (CAC). The Council provides unique opportunities for companies to engage with experts in the brain disease community, not only with patient advocacy organizations, but also with top scientific, clinical, and policy experts and leaders in the worldwide central nervous system space.
CORPORATE ADVISORY COUNCIL MEMBERS

Aequa Nanotherapeutics

Takeda Pharmaceuticals America Inc.

Subsense, Inc.

Neurocrine Biosciences, Inc.

QuantalX Neuroscience

Bristol Myers Squibb

Kernel

Otsuka America Pharmaceutical

Definium Therapeutics

Teva Pharmaceuticals

Floreo

Ionis Pharmaceuticals, Inc.

Mike Hanley
Alto Neuroscience

Eli Lilly & Company

Novartis Pharmaceuticals Corporation

AbbVie Inc.

Eisai, Inc.

Delix Therapeutics

Motif Neurotech
.jpg)
Stoke Therapeutics

Praxis Precision Medicines

Lundbeck

Cognoa

Acadia Pharmaceuticals

TBD
Precision Neuroscience

Genentech
.png)
